Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study

Subjects: Clinic for Radiation Oncology; 610 Medicine & health

  • Source: Kroese, Tiuri E; Takahashi, Yuko; Lordick, Florian; van Rossum, Peter S N; Ruurda, Jelle P; Lagarde, Sjoerd M; van Hillegersberg, Richard; Verhoeven, Rob H A; van Laarhoven, Hanneke W M (2023). Liver

Record details

×
Academic Journal

Diagnosis of Gastric Cancer in the Excluded Stomach After RYGB by Jejunogastrostomy Using a LAMS

Subjects: Clinic for Gastroenterology and Hepatology; 610 Medicine & health

  • Source: Schneider, Luca; Kröger, Arne; Gubler, Christoph; The, Frans Olivier (2022). Diagnosis of Gastric Cancer in the Excluded Stomach After

Record details

×
Academic Journal

Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article

Subjects: Clinic for Oncology and Hematology; 610 Medicine & health

  • Source: Siebenhüner, Alexander R; De Dosso, Sara; Helbling, Daniel; Astaras, Christoforos; Szturz, Petr; Moosmann, Peter; Pederiva, Stefanie; Winder, Thomas; Von Burg, Philippe; Borner, Markus (2021).

Record details

×
Academic Journal

A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial

Subjects: Department of Molecular Mechanisms of Disease; 570 Life sciences; biology

  • Source: Merz, Valeria; Zecchetto, Camilla; Simionato, Francesca; Cavaliere, Alessandro; Casalino, Simona; Pavarana, Michele; Giacopuzzi, Simone; Bencivenga, Maria; Tomezzoli, Anna; Santoro, Raffaela; Fedele,

Record details

×
Academic Journal

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Subjects: Clinic for Oncology and Hematology; 610 Medicine & health

  • Source: Rha, Sun Young; Oh, Do-Youn; Yañez, Patricio; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernández, Manuel González; Li,

Record details

×
Academic Journal

A Double Whammy on Gastric Cancer Risk

Subjects: Institute of Molecular Cancer Research; 570 Life sciences; biology

  • Source: Müller, Anne; He, Jiazhuo (2023). A Double Whammy on Gastric Cancer Risk. New England Journal of Medicine, 388(13):1225-1229.

Record details

×
Academic Journal

Early hereditary diffuse gastric cancer (eHDGC) is characterized by subtle genomic Instability and active DNA damage response

Subjects: Clinic for Visceral and Transplantation Surgery; 610 Medicine & health; Pathology and Forensic Medicine

  • Source: Nasri, Soroush; Humara, Bostjan; Anjomshoaa, Ahmad; Moradi, Nourodin; Gholipour, Naghmeh; Mashjoor, Sakineh; Zhang, Peng (2019). Early hereditary diffuse gastric

Record details

×
Academic Journal

Incidence and mortality trends of gastric cancer in Switzerland 1988-2014

Subjects: Epidemiology; Biostatistics and Prevention Institute (EBPI); 610 Medicine & health

  • Source: Schmidt, Anne; Fleischmann, Achim; Lorez, Matthias; Rohrmann, Sabine (2018). Incidence and mortality trends of gastric cancer in

Record details

×
Academic Journal

Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011

Subjects: Epidemiology; Biostatistics and Prevention Institute (EBPI); 610 Medicine & health

  • Source: Feller, Anita; Fehr, Martin; Bordoni, Andrea; Bouchardy, Christine; Frick, Harald; Mousavi, Mohsen; Steiner, Annik; Arndt, Volker; Clough-Gorr, Kerri M (2015). Trends in incidence of oesophageal and

Record details

×
  • 1-10 of  52 results for ""gastric cancer""